gs arbidol and hydroxychloroquine which tested positive for their ability to induce mutations (Table 4).

3.3.  Docking studies of WS phytoconstituents with respect to selected target proteins
Docking studies of the selected WS phytoconstituents were carried out with human ACE2 receptor, SARS-CoV and SARS-CoV-2 specific proteins. The catalytically active sites of SARS-CoV-2 specific proteins were targeted in order to obtain the